PATENT CLAIM ANALYSIS

Application Number: 16151959
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-04
Patent Classification: ["514", "322000"]

Abstract:
Disclosed are imidazole compounds, as well as pharmaceutical compositions and methods of use thereof. One embodiment is a compound having the structure and pharmaceutically acceptable salts, prodrugs and N-oxides thereof (and solvates and hydrates thereof), wherein X, Y and Z are as described herein. In certain embodiments, a compound disclosed herein inhibits a cellular TAM receptor, and can be used to treat disease mediated by or involving the TAM receptor family.

Claim (Index 35):
The method of  claim 34 , wherein the disease or condition is a hematological neoplasms.

Metadata:
- Claim Count in Document: 25.0
- Percentile: 97.0
- Lexical Diversity: 1.4386
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15645775', '15151259', '15234690', '15624850', '15971017']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7753330964085201
- 35 USC 102 Novelty (BERT): 0.5232957023634741
- Combined Prediction Score: 0.7501293570040155
- Mean Citation Score: 243.933836
- Max Citation Score: 336.62686
- Similarity Product: 291.99906389914275

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test